PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.94%
Negative revenue growth while CVE stands at 16.66%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.60%
Negative gross profit growth while CVE is at 11.95%. Joel Greenblatt would examine cost competitiveness or demand decline.
-162.05%
Negative EBIT growth while CVE is at 27.19%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-162.05%
Negative operating income growth while CVE is at 27.19%. Joel Greenblatt would press for urgent turnaround measures.
-166.34%
Negative net income growth while CVE stands at 1.82%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-166.39%
Negative EPS growth while CVE is at 10.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-168.10%
Negative diluted EPS growth while CVE is at 10.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.23%
Share reduction while CVE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.84%
Reduced diluted shares while CVE is at 0.36%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.41%
Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.
-9.31%
Negative OCF growth while CVE is at 500.44%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-23.06%
Negative FCF growth while CVE is at 361.76%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-51.65%
Negative 10Y revenue/share CAGR while CVE stands at 1.66%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
203.26%
5Y revenue/share CAGR above 1.5x CVE's 50.80%. David Dodd would look for consistent product or market expansions fueling outperformance.
25.20%
3Y revenue/share CAGR above 1.5x CVE's 12.27%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-55.80%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
489.53%
5Y OCF/share CAGR above 1.5x CVE's 175.83%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
14.85%
3Y OCF/share CAGR under 50% of CVE's 56.44%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-166.10%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
77.75%
5Y net income/share CAGR at 50-75% of CVE's 134.65%. Martin Whitman might see a shortfall in operational efficiency or brand power.
1.25%
Below 50% of CVE's 132.64%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-86.86%
Negative equity/share CAGR over 10 years while CVE stands at 0.01%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-47.70%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-55.96%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-90.35%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
48.27%
Stable or rising mid-term dividends while CVE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
29.89%
Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
8.12%
AR growth well above CVE's 3.92%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-5.28%
Negative asset growth while CVE invests at 0.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.62%
We have a declining book value while CVE shows 0.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-14.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
8.45%
SG&A growth well above CVE's 4.29%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.